The ceremony of the opening of trading in the Market for Innovations and Investments (MICEX MII) was held on the MICEX on December 10, 2009. It was timed to the initial public offering of shares in The Human Stem Cells Institute (HSCI), organized by ALOR INVEST.

Investors were offered 15 million shares in HSCI, making up 20% of the Company’s increased authorized capital at the price of 9.5 rubles per share. The IPO was successful: there were over 300 investors, most of them individuals, whose demand for shares exceeded the supply.

On the same day, December 10, the Coordinating Council of the MICEX MII, headed by the RUSNANO‘s CEO Anatoly Chubais, approved the key expert bodies of the Market for Innovations and Investments: the Committee on Direct and Venture Investments and the Working Group on State Support for the Attraction of Private Capital to Russian Innovation Companies.

The Committee and the Working Group will be engaged in searching promising projects and innovation companies, preparing them for entering the stock market and attracting private capital.

According to RUSNANO’s CEO Anatoly Chubais, the creation of the market for innovation companies on the MICEX, where offerings will take place, is the most important strategic initiative, which is an integral part of the system of innovation institutions. “That’s why RUSNANO and the MICEX began to develop a new project, “Russian NASDAQ”, the creation of an exchange for innovation businesses. Today’s IPO made by The Human Stem Cells Institute is a special event. This is the first time in the Russian history that an innovation company has made its IPO under a special procedure”, he said.

The MICEX President of Konstantin Korischenko said: “Today we are launching a new floor, the Market for Innovations and Investments. The MII’s tasks will include the development of a favorable environment that will help companies to enter the market and implement innovations. Next year we expect about ten companies to enter the Market for Innovations and Investments, including high-tech companies from Russian regions, with which we are developing cooperation.

Arthur Isayev, CEO of HSCI, expressed his gratitude to the organizers of the IPO and said: “In the course of the IPO, our Company achieved all its goals. The attracted investment will give additional impetus to the development of the Company. They will help us to enter new markets, bring new therapeutic products to the market and secure our leadership positions.”

Brief information:

*The MICEX Group* is an integrated exchange which provides services related to electronic trading, clearing, settlements as well as depository and information services on the basis of a single technological platform.
The Group is comprised of the MICEX, the MICEX Stock Exchange, the National Mercantile Exchange, the MICEX Settlement House, not-for-profit partnership The National Depository Centre, commercial bank National Clearing Centre (closed joint-stock company), The MICEX – Information Technologies Company, regional exchange and settlement centers. The Group serves over 1700 participants in the on-exchange market - leading Russian banks and broker companies from Moscow and other large financial and industrial centers of Russia. At present, the MICEX Group operates a number of key financial markets: the currency market, the government bonds market, the share market, the market for corporate and regional bonds, the derivatives market and the money market.
The Market for Innovations and Investments is a project to create an exchange floor for high-tech companies, implemented jointly by the MICEX and RUSNANO Corporation.

*The Market for Innovations and Investments* has three main segments intended for companies with different maturity and capitalization and different groups of investors:
-The Innovation and Growth Companies Sector (IGC): helps innovation companies to make public offerings (IPO/SPO), enables to admit securities to secondary trading in all modes of trading on the MICEX SE.
-IGC-2: is intended for private offerings with the use of exchange technologies and listing. Secondary trading is held among qualified investors with the use of trading technologies designed for trading in large blocks of securities (in the negotiated deals mode (CPF).
-Information board: a web site aimed at creating mechanisms to attract investments to innovation companies in the early stages of their development.

*The Russian Corporation of Nanotechnologies* was established in 2007 to effect Government policy in the field of nanotechnology. RUSNANO co-invests in nanotechnology industry projects that have high commercial potential or considerable social benefit. Early-stage investment by RUSNANO lowers the risks to partners in investment from the private sector. RUSNANO aims to encourage the growth of Russian nanotech industry to the level of annual sales of 900 bln rubles by 2015. The sales of nanoproducts by companies invested by RUSNANO are aimed at 300 bln rubles. RUSNANO organizes the annual Nanotechnology International Forum in Russia. For more information please refer to www.rusnano.com
The Human Stem Cell Institute (HSCI) was established in 2003 to advance projects in stem cell technologies. Today, HSCI is an international biotechnological company with laboratories and offices in Moscow, St. Petersburg, Ukraine and Germany. HSCI has up-to-date processing laboratories and storages of cellular material. It uses research laboratories, such as the Laboratory of Stem Cell Technologies in Moscow and the biotechnological laboratory of SymbioTec Co. in Saarbrücken (Germany). The Institute publishes the scientific journal Cellular Transplantation and Tissue Engineering.
http://www.hsci.ru/

Return

MICEX and RUSNANO launch trading in the Market for Innovations and Investments